Biotechnology - Seoul, , South Korea
SP2 Therapeutics (SP2TX) is a bioinformatics aided drug discovery company with a disruptive and proprietary peptide/protein chemical synthesis platform. Our technology industrializes on-demand engineering and non-ribosomal manufacturing of fully functional mini-proteins that can expand the universe of the human proteome. SP2TX's mission is to bring the efficacy of biopharmaceutical drugs to the world at the cost of traditional small molecule drugs.